Exploring the latest advances in 18 F-FDG PET/CT and cardiac magnetic resonance for imaging for cardiac sarcoidosis diagnosis.
| Autor: | Miratashi Yazdi SN; Advanced Diagnostic and Interventional Radiology Research Center (ADIR), Tehran University of Medical Sciences Tehran, Iran., Riahi F; Department of Radiology, Isfahan University of Medical Sciences Isfahan, Iran., Azizollahi S; Department of Radiology, Isfahan University of Medical Sciences Isfahan, Iran., Tooyserkani SH; School of Medicine, Isfahan University of Medical Sciences Isfahan, Iran., Fesharaki S; Department of Radiology, Isfahan University of Medical Sciences Isfahan, Iran., Alaei M; School of Medicine, Shahid Beheshti University of Medical Sciences Tehran, Iran., Ghazanfari Hashemi M; Cancer Institute, Department of Radiology, Imam Khomeini Hospital, Tehran University of Medical Sciences Tehran, Iran., Vakili Zarch M; Department of Radiology, Isfahan University of Medical Sciences Isfahan, Iran., Mojahedi A; Department of Internal Medicine, Stony Brook University Hospital Stony Brook, New York, The United States. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | American journal of nuclear medicine and molecular imaging [Am J Nucl Med Mol Imaging] 2024 Apr 25; Vol. 14 (2), pp. 149-156. Date of Electronic Publication: 2024 Apr 25 (Print Publication: 2024). |
| DOI: | 10.62347/GIKK5707 |
| Abstrakt: | Sarcoidosis is a systemic inflammatory disease that affects multiple organs. Various clinical signs are associated with cardiac sarcoidosis (CS), and the diagnosis process is complicated because any organ could be involved. Despite the critical clinical importance of early and precise diagnosis of CS, there is currently no gold-standard method for CS evaluation. The non-invasive imaging modalities of 18 F-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG PET/CT) and cardiac magnetic resonance (CMR) imaging have demonstrated the potential for identifying various histological characteristics of CS. Recently, the development of hybrid FDG-PET/CMR scanners has enabled the simultaneous acquisition of these attributes. Compared to just one imaging modality, these scanners detect CS and stratify risk more accurately and with higher sensitivity. Analyzing the potential role of concurrent FDG-PET/CMR in enhancing the diagnosis of CS, the present review concentrates on the advantages of this technique in light of recent technological developments. Competing Interests: None. (AJNMMI Copyright © 2024.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|